Well there's some new and novel things currently going through clinical trials for UC. Some of them are for more mild treatments. A good example is QuBiologics SSI, /www.quibd.com/ssi-intro/how-ssi-may-work/
, which is being clinical trialed with mild to moderate UC cases.
There's a Crohn's Vaccine that's in clinical trials (based on the whole MAP/Johne's-Disease/tuberculosis theory) that would be prescribed to a broad spectrum of Crohn's and possibly UC cases (dependent on results). www.crohnsmapvaccine.com/
There's a number of new biologics which do get the most attention, as it takes care of the most severe cases. Certainly research is very, very expensive and many drugs do not make it through the trial process. I forget the exact ratio, something like 1-in-3 drugs make it to market and the cost can be many millions for an attempt (development, clinical trial vetting, etc.). Biologics have the biggest return on investment (with one infusion getting $5,000.00-$10,000.00 or more and a lifetime of said drug). New pills might earn $1000.00 a month (same timeframe as prior example). In the end it is a business, and Humira, Remicade, and others are blockbuster successes in sales, making the pharmaceutical company tons of cash (often 2/3 of that company's profit for a year). If you're developing a new drug, hard not to look at those big numbers and not follow suit. I wish was all empathetic causes but it is a capitalistic society.
Moderator Ulcerative Colitis
John, 40, UC Proctosigmoiditis
Rx: Remicade @5mgs/kg/6wks; daily 75mgs 6MP, 4.8g generic-Lialda, and rowasaHow long a minute is depends on which side of the bathroom door you are on.
Post Edited (iPoop) : 10/1/2018 8:05:12 AM (GMT-6)